Biomx Ltd (PHGE) Stock Price, Quote & News

Company Profile

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. It also developing BX004, a phage therapy for cystic fibrosis and non-cystic fibrosis bronchiectasis patients with chronic pulmonary infections caused by P...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 7 2394 2377

Website: www.biomx.com

Address:

22 Einstein Street, Floor 4, Ness Ziona, Israel

StockHolms Nov. 15 at 1:46 AM

$PHGE Not the best news … however, I’ve seen and had some pretty sweet gains around reverse splits. So, I’ll hang in there with a .38 average. This is the penny stock biotech game 🥳

0 · Reply

SaySomethingNice Nov. 14 at 10:11 PM

$PHGE I added more 👍 Tyvm

0 · Reply

Rambu11 Nov. 14 at 9:40 PM

$PHGE all the signs where there when it broke .40

0 · Reply

TWITLIEDETECTOR Nov. 14 at 2:16 AM

$PHGE is this thing dead? under $1 too long

1 · Reply

AllHailTrump2024 Nov. 14 at 1:54 AM

$PHGE guys I just want you to know I had to stick with my promise and I sold a few days ago all my 69k shares at .4101. Made a few thousand dollars. I have to say I got lucky because I’m seeing what’s happening. I still believe this will make some people rich but it won’t Happen until next year. I unfortunately can’t wait until then. GLTA and be strong and hold if truly believe.

1 · Reply

StockHolms Nov. 13 at 8:27 PM

$PHGE comfortable adding some here for a .38 average. 52 week low territory, catalyst potential in the form of FDA news … it’s a decent set-up for what it is.

0 · Reply

AllHailTrump2024 Nov. 13 at 4:18 PM

$PHGE

0 · Reply

SaySomethingNice Nov. 12 at 9:29 PM

$PHGE Ceo must do a better skill at presentation and pr news in proper context, imo.. I know, company has multiple projects, multiple clinical-stage, and multiple results needs to be address in Q1 2026 and through out 2026.. Maybe, Ceo needs to pr news ONE AT A TIME clinical topic and then, at the bottom, inform INVESTORS more updates ahead.. I think a better presentation and a better video image of the context for NON-BIOTECH players to see, understand, and to know the true potential of $PHGE The stock has so much potential to blastoff.. Just need some re-adjustment in how to present to investors.. - Imo always.. Glta..

0 · Reply

StockHolms Nov. 12 at 5:31 PM

$PHGE Holding two stocks with earnings this week - $PHGE AND $BFRI. Not a fan 😬 of earnings for these micros but it is what it is. Holding the line between respecting my risk and being patient with conviction. I think both names have potential to produce sweet gains. Typically, big moves don’t come from earnings on these biotechs because they are all cash strapped. Keeping size in check lessens the emotional attachment. Staying patient can be difficult. SEND IT!!

0 · Reply

Rambu11 Nov. 12 at 4:01 PM

$PHGE added here! There playing games today

1 · Reply

BiomX Inc. (PHGE) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:30 AM EST - 2 days ago

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

Oct 17, 2025, 8:30 AM EDT - 4 weeks ago

BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways

Aug 19, 2025, 8:19 AM EDT - 3 months ago

BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis

Aug 13, 2025, 11:48 AM EDT - 3 months ago

BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 6:30 AM EDT - 3 months ago

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Aug 6, 2025, 8:30 AM EDT - 3 months ago

BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025

Jul 14, 2025, 9:00 AM EDT - 4 months ago

BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis

Jul 8, 2025, 8:30 AM EDT - 4 months ago

BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis

May 19, 2025, 10:02 AM EDT - 6 months ago

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

May 15, 2025, 4:57 PM EDT - 6 months ago

BiomX Inc. (PHGE) Q1 2025 Earnings Conference Call Transcript

May 15, 2025, 6:30 AM EDT - 6 months ago

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

May 8, 2025, 7:00 AM EDT - 6 months ago

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

Apr 1, 2025, 6:30 AM EDT - 8 months ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

Mar 31, 2025, 6:30 AM EDT - 8 months ago

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

Mar 25, 2025, 6:30 AM EDT - 8 months ago

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

Mar 19, 2025, 12:35 PM EDT - 8 months ago

BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Nov 14, 2024, 10:20 AM EST - 1 year ago

BiomX Inc. (PHGE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 6:30 AM EST - 1 year ago

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates

Nov 12, 2024, 12:20 PM EST - 1 year ago

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Oct 15, 2024, 7:00 AM EDT - 1 year ago

BiomX Announces a Mandatory Unit Separation

Sep 18, 2024, 8:00 AM EDT - 1 year ago

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference

Sep 4, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 16, 2024, 10:55 AM EDT - 1 year ago

UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 12:03 PM EDT - 1 year ago

BiomX Inc. (PHGE) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 6:30 AM EDT - 1 year ago

BiomX Inc. Announces 1-for-10 Reverse Stock Split

Aug 15, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program Updates

Aug 8, 2024, 7:00 AM EDT - 1 year ago

BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024

Jul 31, 2024, 7:35 AM EDT - 1 year ago

Top 3 Health Care Stocks That May Explode In Q3

DXCM EW

Jul 29, 2024, 7:00 AM EDT - 1 year ago

BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Jul 10, 2024, 6:30 AM EDT - 1 year ago

BiomX Inc. Announces Stockholder Approval for Conversion of Outstanding Series X Convertible Preferred Stock to Common Stock

May 30, 2024, 4:50 PM EDT - 1 year ago

BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

May 30, 2024, 7:00 AM EDT - 1 year ago

BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

May 21, 2024, 10:25 AM EDT - 1 year ago

BiomX (PHGE) Q1 2024 Earnings Call Transcript

May 21, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

May 15, 2024, 7:00 AM EDT - 1 year ago

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

Apr 23, 2024, 8:00 AM EDT - 1 year ago

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Apr 18, 2024, 8:00 AM EDT - 1 year ago

BiomX Announces the Appointment of Susan Blum to its Board of Directors

Apr 3, 2024, 12:26 PM EDT - 1 year ago

BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript

Apr 3, 2024, 6:30 AM EDT - 1 year ago

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 27, 2024, 6:30 AM EDT - 1 year ago

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

Mar 18, 2024, 6:30 AM EDT - 1 year ago

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Mar 6, 2024, 7:30 AM EST - 1 year ago

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Jan 4, 2024, 8:00 AM EST - 2 years ago

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

Nov 30, 2023, 4:15 PM EST - 2 years ago

BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023

Nov 29, 2023, 6:30 AM EST - 2 years ago

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

Nov 23, 2023, 7:43 AM EST - 2 years ago

BiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any Day

Nov 14, 2023, 6:30 AM EST - 2 years ago

BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

Oct 27, 2023, 8:00 AM EDT - 2 years ago

BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference

StockHolms Nov. 15 at 1:46 AM

$PHGE Not the best news … however, I’ve seen and had some pretty sweet gains around reverse splits. So, I’ll hang in there with a .38 average. This is the penny stock biotech game 🥳

0 · Reply

SaySomethingNice Nov. 14 at 10:11 PM

$PHGE I added more 👍 Tyvm

0 · Reply

Rambu11 Nov. 14 at 9:40 PM

$PHGE all the signs where there when it broke .40

0 · Reply

TWITLIEDETECTOR Nov. 14 at 2:16 AM

$PHGE is this thing dead? under $1 too long

1 · Reply

AllHailTrump2024 Nov. 14 at 1:54 AM

1 · Reply

StockHolms Nov. 13 at 8:27 PM

$PHGE comfortable adding some here for a .38 average. 52 week low territory, catalyst potential in the form of FDA news … it’s a decent set-up for what it is.

0 · Reply

AllHailTrump2024 Nov. 13 at 4:18 PM

$PHGE

0 · Reply

SaySomethingNice Nov. 12 at 9:29 PM

0 · Reply

StockHolms Nov. 12 at 5:31 PM

0 · Reply

Rambu11 Nov. 12 at 4:01 PM

$PHGE added here! There playing games today

1 · Reply

Rambu11 Nov. 12 at 2:35 PM

$PHGE I’d cover today and move on. Future looks bright!!

0 · Reply

StockHolms Nov. 12 at 2:23 PM

$PHGE Earnings are always a gamble, especially with penny stock biotechs. Nothing about earnings points to a big movement in either direction and that’s a win for now. Will keep my risk in place, add if it makes sense and see what happens as we roll into 2026.

0 · Reply

Rambu11 Nov. 12 at 1:52 PM

$PHGE

0 · Reply

SaySomethingNice Nov. 12 at 1:47 PM

$PHGE Q&A.. Talking about DHA. Foot diabetic.. Fast track.. May have more funding $$$ in diabetic, potentially?? tbd...

0 · Reply

MAGANOMICS_BULL Nov. 12 at 1:47 PM

$PHGE my thesis here based on my interpretation

0 · Reply

SaySomethingNice Nov. 12 at 1:44 PM

$PHGE Listening CC rn.

0 · Reply

SaySomethingNice Nov. 12 at 1:31 PM

$AIRE $ASST $DVLT $PHGE Expecting greenday $$$ ahead... - IMO ( nfa )

0 · Reply

STSimu Nov. 12 at 1:26 PM

$PHGE pump and dump

1 · Reply

MAGANOMICS_BULL Nov. 12 at 12:50 PM

$PHGE Enough said right here https://fintel.io/sfo/us/phge

0 · Reply

SaySomethingNice Nov. 12 at 12:47 PM

$PHGE bullish asf 💪

0 · Reply

Rambu11 Nov. 12 at 12:42 PM

$PHGE smoked the projected earnings. 📈❤️

0 · Reply

MAGANOMICS_BULL Nov. 12 at 12:36 PM

$PHGE in case anyone needs to sign up for meeting

0 · Reply

Market Cap	9.29M
Revenue (ttm)	0.00
Net Income (ttm)	-17.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,581,400
Avg Vol	873,108
Day's Range	N/A - N/A
Shares Out	26.56M
Stochastic %K	25%
Beta	1.46
Analysts	Sell
Price Target	$15.00